Page 371 - Binder2

The Hidden Costs of Our Delivery Obsession

Delivery has become one of the most expensive
components of biologic care:

• Cold-chain failures lead to billions in wasted drugs
every year.
• Infusion infrastructure adds layers of cost, time, and
access barriers.
• Hospitals and specialty pharmacies profit more
from administering drugs than from curing
disease.

Patients lose hours, days, and often years to a model that
prioritizes control over comfort, billing over biology.

And globally, this system is a nonstarter—cold storage and
infusion chairs don’t exist in most of the places where
biologics are needed most.

A New Paradigm: Delivery by Design

But what if we started over?

What if, instead of designing biologics that require this
infrastructure, we designed biologics that bypass it?

What if:

• The drug was shelf-stable from the start?
• The delivery was oral, not injectable?
• The therapy was grown in a plant, not purified in a
reactor?
• The production was local, not global?

369